Apr 24, 2025, 08:29 AM by

The press release highlights key advantages of the Green DNA/RNA Dry Transport System: it eliminates the need for cold chain logistics (such as dry ice and Styrofoam), drastically reducing environmental impact and shipping costs, while maintaining the integrity of DNA and RNA samples at room temperature. This innovation is ideal for transporting sequencing-ready libraries for any commercial platform, making it especially valuable for researchers and professionals needing fast, reliable, and sustainable sample transport solutions.

Apr 24, 2025, 08:29 AM by

Apr 24, 2025, 08:29 AM by

Apr 24, 2025, 08:29 AM by

Biodesix, Inc (Nasdaq: BDSX), a leading diagnostics solutions company, and Bio-Rad Laboratories (NYSE: BIO), a global leader in life science research and diagnostics products, contributed to new research findings from Friends of Cancer Research’s (Friends’) ctMoniTR Project, recently published in Clinical Cancer Research (CCR).

Apr 24, 2025, 08:29 AM by

BioSkryb Genomics and Ultima Genomics have launched a joint grant program to accelerate oncology research by providing scientists with access to cutting-edge multi-omic and sequencing technologies. The collaboration pairs BioSkryb’s ultra–low-input single-cell and multi-omic platforms with Ultima’s scalable, cost-efficient sequencing, enabling researchers to explore complex cancer biology with high resolution and reduced cost barriers. The grant will award selected projects with comprehensive studies covering up to 2,000 single-cell genomes at no charge, prioritizing innovative work in somatic mosaicism, clonal heterogeneity, residual disease, and ultra–low-input samples. Applications are due June 20, 2025.

Apr 24, 2025, 08:29 AM by

Real-world evidence supports Viz ICH Plus for reliable volume and midline shift estimation.

Apr 23, 2025, 01:00 AM by User Not Found

Bio-IT World | After years of contributing to the Bio-IT World community as a speaker, awards program judge, and leading consultant, technology expert Chris Dwan took the plenary stage at the 2025 Bio-IT World Conference & Expo, sharing wisdom gleaned from over two decades of building computing infrastructures for the New York Genome Center, Broad Institute, and Sema4 and others.

Apr 22, 2025, 08:15 AM by

New xGen™ hybridization and wash offering is poised to revolutionize targeted next generation sequencing workflows

Apr 22, 2025, 08:15 AM by

Symbiosis Pharmaceutical Services, a specialist sterile manufacturing CMO, who has been formally recognised by EcoVadis for its continued commitment to sustainability.

Apr 22, 2025, 01:00 AM by User Not Found

Bio-IT World | An expert panel of technology and pharmaceutical executives convened at this month's Bio-IT World Venture, Innovation, and Partnering event to discuss the transformative potential of artificial intelligence in drug development—and the significant challenges that still lie ahead. Participants included Rory Kelleher of NVIDIA, Bill Fitzgerald from Google Cloud, Bill Mayo of Bristol-Myers Squibb, Anthony Philippakis of GV (formerly Google Ventures), and Becky Stevenson of HSBC, moderated by Jeremy Goldberg of Arsenal Capital Partners.

Apr 17, 2025, 01:00 AM by User Not Found

Bio-IT World | At the Bio-IT World Conference & Expo earlier this month, Alex Zhavoronkov, CEO and founder of Insilico Medicine, shared the company's progress in leveraging generative AI to accelerate drug discovery, particularly focusing on aging research. Celebrating the company's 11th year, Zhavoronkov emphasized his singular mission: helping people live longer, healthier lives.

Apr 16, 2025, 06:40 AM by

CluePoints, provider of leading statistical and AI-driven software solutions, has been named as a finalist in the ‘Innovative Clinical Trial Solutions’ category at the 2025 Citeline Awards.

Apr 16, 2025, 06:40 AM by

VieCure is making thousands of the most commonly used NCCN Chemotherapy Order Templates available on its Halo Intelligence Platform.

Apr 16, 2025, 01:00 AM by User Not Found

Bio-IT World | During the final plenary keynote of this year’s Bio-IT World Conference & Expo, we heard from Tris Dyson, Challenge Works, and Jeffrey Rothstein, Johns Hopkins University; Robert Green, Harvard Medical School; and Justin Scheer, Johnson & Johnson Innovative Medicine. They all gave presentations that highlighted artificial intelligence (AI) and machine learning’s (ML) ever-growing roles in research and healthcare, as well as the impact they have on the future of patient treatment, drug development, and more.

Apr 15, 2025, 06:35 AM by

Oxford Nanopore Technologies announced the expansion of its Compatible Products Program. New participating companies include: 10x Genomics, Agilent Technologies, Asuragen, Day Zero Diagnostics, Hamilton Robotics, NEB, Opentrons, Pathosense, and Thermo Fisher Scientific.

Apr 15, 2025, 06:35 AM by

The launch of a new mid-sized CDMO, Meribel Pharma Solutions, bringing together 10 manufacturing sites and 3 development centres across Europe. The team – including ex-Synerlab and Catalent leadership – aims to offer agile, high-quality solutions across OSD, sterile, and semi-solid manufacturing. Built on a strong legacy, the company is filling a much-needed niche in the market with centres of excellence in lyophilisation, preservative-free multidose tech, and more.

Apr 15, 2025, 01:00 AM by User Not Found

Bio-IT World | At last week’s Venture, Innovation, and Partnering Summit at the Bio-IT World Conference & Expo, Derek Lowe, Director, Chemical Biology & Therapeutics at Novartis BioMedical Research, and John Keilty, venture partner at Third Rock Ventures, sat down for a candid conversation on the pharmaceutical industry and the current state of artificial intelligence and machine learning (AI/ML) in drug discovery.

Apr 14, 2025, 12:57 PM by

● Membrane proteins synthesized and purified within 48 hours. ● Active membrane transporter, MsbA and integral membrane protein, ZMPSTE24 synthesized

Apr 11, 2025, 08:06 AM by

Apr 11, 2025, 08:06 AM by

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been shortlisted in the ‘CRO Partnership of the Year’ category at the 2025 Citeline Awards for its collaboration with Medicines Development for Global Health (MDGH), a not for profit pharmaceutical company dedicated to the development of affordable medicines for the people who need them most.